News
February 2, 2023
IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
Additional Formats
January 17, 2023
IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors
Additional Formats
January 9, 2023
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
Additional Formats
January 3, 2023
IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Additional Formats